» Articles » PMID: 35684753

A Model for Predicting Cervical Cancer Using Machine Learning Algorithms

Overview
Journal Sensors (Basel)
Publisher MDPI
Specialty Biotechnology
Date 2022 Jun 10
PMID 35684753
Authors
Affiliations
Soon will be listed here.
Abstract

A growing number of individuals and organizations are turning to machine learning (ML) and deep learning (DL) to analyze massive amounts of data and produce actionable insights. Predicting the early stages of serious illnesses using ML-based schemes, including cancer, kidney failure, and heart attacks, is becoming increasingly common in medical practice. Cervical cancer is one of the most frequent diseases among women, and early diagnosis could be a possible solution for preventing this cancer. Thus, this study presents an astute way to predict cervical cancer with ML algorithms. Research dataset, data pre-processing, predictive model selection (PMS), and pseudo-code are the four phases of the proposed research technique. The PMS section reports experiments with a range of classic machine learning methods, including decision tree (DT), logistic regression (LR), support vector machine (SVM), K-nearest neighbors algorithm (KNN), adaptive boosting, gradient boosting, random forest, and XGBoost. In terms of cervical cancer prediction, the highest classification score of 100% is achieved with random forest (RF), decision tree (DT), adaptive boosting, and gradient boosting algorithms. In contrast, 99% accuracy has been found with SVM. The computational complexity of classic machine learning techniques is computed to assess the efficacy of the models. In addition, 132 Saudi Arabian volunteers were polled as part of this study to learn their thoughts about computer-assisted cervical cancer prediction, to focus attention on the human papillomavirus (HPV).

Citing Articles

Comparative analysis of machine learning approaches for predicting the risk of vaginal laxity.

Zhao H, Liu P, Chen F, Wang M, Liu J, Fu X Sci Rep. 2025; 15(1):3147.

PMID: 39856162 PMC: 11760964. DOI: 10.1038/s41598-025-86931-x.


CerviXpert: A multi-structural convolutional neural network for predicting cervix type and cervical cell abnormalities.

Akash R, Islam R, Badhon S, Hossain K Digit Health. 2024; 10:20552076241295440.

PMID: 39529914 PMC: 11552049. DOI: 10.1177/20552076241295440.


Predictive models for personalized precision medical intervention in spontaneous regression stages of cervical precancerous lesions.

He S, Zhu G, Zhou Y, Yang B, Wang J, Wang Z J Transl Med. 2024; 22(1):686.

PMID: 39061062 PMC: 11282852. DOI: 10.1186/s12967-024-05417-y.


Dynamic Price Application to Prevent Financial Losses to Hospitals Based on Machine Learning Algorithms.

Atalan A, Donmez C Healthcare (Basel). 2024; 12(13).

PMID: 38998807 PMC: 11241456. DOI: 10.3390/healthcare12131272.


Prediction of precancerous cervical cancer lesions among women living with HIV on antiretroviral therapy in Uganda: a comparison of supervised machine learning algorithms.

Namalinzi F, Galadima K, Nalwanga R, Sekitoleko I, Uwimbabazi L BMC Womens Health. 2024; 24(1):393.

PMID: 38978015 PMC: 11229242. DOI: 10.1186/s12905-024-03232-7.


References
1.
Zelasko D, Ksiazek W, Plawiak P . Transmission Quality Classification with Use of Fusion of Neural Network and Genetic Algorithm in Pay&Require Multi-Agent Managed Network. Sensors (Basel). 2021; 21(12). PMC: 8231990. DOI: 10.3390/s21124090. View

2.
Kable A, Pich J, Maslin-Prothero S . A structured approach to documenting a search strategy for publication: a 12 step guideline for authors. Nurse Educ Today. 2012; 32(8):878-86. DOI: 10.1016/j.nedt.2012.02.022. View

3.
Matsuo K, Purushotham S, Jiang B, Mandelbaum R, Takiuchi T, Liu Y . Survival outcome prediction in cervical cancer: Cox models vs deep-learning model. Am J Obstet Gynecol. 2018; 220(4):381.e1-381.e14. PMC: 7526040. DOI: 10.1016/j.ajog.2018.12.030. View

4.
Mukama T, Ndejjo R, Musabyimana A, Halage A, Musoke D . Women's knowledge and attitudes towards cervical cancer prevention: a cross sectional study in Eastern Uganda. BMC Womens Health. 2017; 17(1):9. PMC: 5282746. DOI: 10.1186/s12905-017-0365-3. View

5.
Sarenac T, Mikov M . Cervical Cancer, Different Treatments and Importance of Bile Acids as Therapeutic Agents in This Disease. Front Pharmacol. 2019; 10:484. PMC: 6558109. DOI: 10.3389/fphar.2019.00484. View